Inotropic Stimulation and Myocardial Energetics
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Steinkopff

9783662079102, 9783662079089

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_21 ◽

1989 ◽

pp. 213-224 ◽

Cited By ~ 2

Author(s):

K. Chatterjee

Keyword(s):

Phosphodiesterase Inhibitors

Download Full-text

Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility?

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_13 ◽

1989 ◽

pp. 135-144

Author(s):

Otto-Erich Brodde ◽

H.-R. Zerkowski

Keyword(s):

Heart Rate ◽

Physiological Role ◽

Beta 2

Download Full-text

Ca-Agonists: a new class of inotropic drugs

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_10 ◽

1989 ◽

pp. 105-116

Author(s):

M. Bechem ◽

R. Gross ◽

S. Hebisch ◽

M. Schramm

Keyword(s):

New Class ◽

Inotropic Drugs

Download Full-text

Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_19 ◽

1989 ◽

pp. 191-196

Author(s):

Gerd Hasenfuss ◽

Hj. Just

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Clinical Relevance ◽

Term Therapy ◽

Chronic Congestive Heart Failure ◽

Dopamine Analogues ◽

Long Term Therapy ◽

Orally Active

Download Full-text

Studies on the mechanism of action of the bipyridine milrinone on the heart

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_9 ◽

1989 ◽

pp. 85-103

Author(s):

A. E. Farah ◽

C. J. Frangakis

Keyword(s):

Mechanism Of Action

Download Full-text

Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_17 ◽

1989 ◽

pp. 177-186

Author(s):

T. Meinertz ◽

H. Drexler ◽

Hj. Just

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Clinical Situation ◽

Pharmacological Activities

Download Full-text

Myofibrillar Ca+ + activation and heart failure — Ca+ + sensitization by the cardiotonic agent APP 201–533

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_11 ◽

1989 ◽

pp. 117-124

Author(s):

J. W. Herzig ◽

L. H. Botelho ◽

R. J. Solaro

Keyword(s):

Heart Failure ◽

Cardiotonic Agent

Download Full-text

The use of levodopa, an oral dopamine precursor, in congestive heart failure

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_18 ◽

1989 ◽

pp. 187-190 ◽

Cited By ~ 1

Author(s):

George Broderick ◽

S. I. Rajfer

Keyword(s):

Heart Failure ◽

Congestive Heart Failure

Download Full-text

Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_8 ◽

1989 ◽

pp. 69-83

Author(s):

Masao Endoh

Keyword(s):

Cyclic Amp ◽

Intracellular Calcium ◽

Muscarinic Receptor ◽

Calcium Transients

Download Full-text

Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy

Inotropic Stimulation and Myocardial Energetics ◽

10.1007/978-3-662-07908-9_25 ◽

1989 ◽

pp. 257-265

Author(s):

Ch. Holubarsch ◽

G. Hasenfuss ◽

M. Allgeier ◽

H. W. Heiss ◽

Hj. Just

Keyword(s):

Dilated Cardiomyopathy ◽

Positive Inotropism ◽

Myocardial Energetics

Download Full-text

Inotropic Stimulation and Myocardial EnergeticsLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Steinkopff

Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics

Do human cardiac beta-2 adrenoceptors play a (patho)physiological role in regulation of heart rate and/or contractility?

Ca-Agonists: a new class of inotropic drugs

Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure

Studies on the mechanism of action of the bipyridine milrinone on the heart

Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?

Myofibrillar Ca+ + activation and heart failure — Ca+ + sensitization by the cardiotonic agent APP 201–533

The use of levodopa, an oral dopamine precursor, in congestive heart failure

Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism

Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy

Inotropic Stimulation and Myocardial Energetics
Latest Publications